Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001824293-25-000102
Filing Date
2025-08-13
Accepted
2025-08-13 17:30:02
Documents
18
Effectiveness Date
2025-08-13

Document Format Files

Seq Description Document Type Size
1 S-8 august2025s-8.htm S-8 64341
2 EX-FILING FEES exfilingfees.htm   iXBRL EX-FILING FEES 24532
3 EX-5.1 exhibit51-august25sx8.htm EX-5.1 12220
4 EX-23.1 exhibit231-august25sx8.htm EX-23.1 2170
5 EX-99.1 exhibit994-august25sx8.htm EX-99.1 48579
6 GRAPHIC image_0.jpg GRAPHIC 16879
7 GRAPHIC image_8.jpg GRAPHIC 1656
8 GRAPHIC mintzlogo.jpg GRAPHIC 256272
  Complete submission text file 0001824293-25-000102.txt   648095

Data Files

Seq Description Document Type Size
21 EXTRACTED XBRL INSTANCE DOCUMENT exfilingfees_htm.xml XML 4953
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037 (619) 400-1171
GRI Bio, Inc. (Filer) CIK: 0001824293 (see all company filings)

EIN.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-289593 | Film No.: 251213143
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)